Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is a two-year double blind, placebo-controlled, and randomized clinical trial, which is
aimed to evaluate the effects of Chinese medical treatment on leucopenia after chemotherapy
in breast cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
China Medical University Hospital
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)